Comparative effectiveness of surgery and radiotherapy for survival of patients with clinically localized prostate cancer: A population‑based coarsened exact matching retrospective cohort study

Yasui,Masato; Sakaguchi,Masahiko; Jikuya,Ryousuke; Tsutsumi,Sohgo; Tatenuma,Tomoyuki; Noguchi,Go; Umemoto,Susumu; Katayama,Kayako; Narimatsu,Hiroto; Uemura,Hiroji; Kishida,Takeshi

doi:10.3892/ol.2020.12013

Comparative effectiveness of surgery and radiotherapy for survival of patients with clinically localized prostate cancer: A population‑based coarsened exact matching retrospective cohort study

Authors:
- Masato Yasui
- Masahiko Sakaguchi
- Ryousuke Jikuya
- Sohgo Tsutsumi
- Tomoyuki Tatenuma
- Go Noguchi
- Susumu Umemoto
- Kayako Katayama
- Hiroto Narimatsu
- Hiroji Uemura
- Takeshi Kishida
View Affiliations

Affiliations: Department of Urology, Kanagawa Cancer Center, Yokohama, Kanagawa 241‑8515, Japan, Kanagawa Cancer Center Research Institute, Yokohama, Kanagawa 241‑8515, Japan, Department of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Kanagawa 232‑0024, Japan
Published online on: August 24, 2020 https://doi.org/10.3892/ol.2020.12013
Article Number: 150
Copyright: © Yasui et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Radical prostatectomy and radiotherapy are currently the main treatment options for localized prostate cancer. However, no large cohort study comparing surgery and radiation has been performed in Japan or Asia. The objective of the current study was to compare the survival outcomes of patients with clinically localized prostate cancer and in elderly and young patients receiving surgery and radiotherapy. The survival outcomes of patients with localized prostate cancer (age at diagnosis ≤79 years, clinical T1‑3) initially treated with surgery or radiotherapy were retrospectively analyzed. Data were collected from the population‑based cancer registry of the Kanagawa Prefecture, Japan. A 1:1 coarsened exact matching of age at diagnosis, clinical T stage and cancer differentiation was performed between the two treatment groups. Patients were also categorized into two subgroups by age using a cutoff of 70 years for analysis. The cohort comprised 4,810 patients aged 50‑79 years. No significant difference in cancer‑specific survival (CSS) was observed between the two groups (P=0.612). However, the surgery group had significantly better overall survival (OS; P=0.004). When stratified for age, similar tendencies were observed in the elderly group (aged 70‑79 years; CSS, P=0.961 and OS, P=0.007). No significant difference in either CSS or OS was identified in the younger group (P=0.550 and P=0.408, respectively). Intrinsic deaths were more likely to occur in elderly patients treated with radiotherapy than those undergoing surgery (69.3 vs. 78.2%; P=0.128). The results indicated that surgery provided significantly better OS than radiotherapy, particularly among the elderly. However, no significant difference was observed in CSS. These results should be interpreted with caution, given that some important factors were unavailable in the present study, such as prostate‑specific antigen values and Gleason scores. Prospective trials evaluating these therapies are warranted.

View Figures

View References

1	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
2	Kimura T and Egawa S: Epidemiology of prostate cancer in Asian countries. Int J Urol. 25:524–531. 2018. View Article : Google Scholar : PubMed/NCBI
3	Hamdy FC, Donovan JL, Lane JA, Mason M, Metcalfe C, Holding P, Davis M, Peters TJ, Turner EL, Martin RM, et al: 10-Year Outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med. 375:1415–1424. 2016. View Article : Google Scholar : PubMed/NCBI
4	Lane JA, Donovan JL, Davis M, Walsh E, Dedman D, Down L, Turner EL, Mason MD, Metcalfe C, Peters TJ, et al: Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: Study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial. Lancet Oncol. 15:1109–1118. 2014. View Article : Google Scholar : PubMed/NCBI
5	Wallis CJD, Saskin R, Choo R, Herschorn S, Kodama RT, Satkunasivam R, Shah PS, Danjoux C and Nam RK: Surgery Versus radiotherapy for clinically-localized prostate cancer: A systematic review and meta-analysis. Eur Urol. 70:21–30. 2016. View Article : Google Scholar : PubMed/NCBI
6	Abdollah F, Schmitges J, Sun M, Jeldres C, Tian Z, Briganti A, Shariat SF, Perrotte P, Montorsi F and Karakiewicz PI: Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: A population-based analysis. Int J Urol. 19:836–844. 2012. View Article : Google Scholar : PubMed/NCBI
7	Sooriakumaran P, Nyberg T, Akre O, Haendler L, Heus I, Olsson M, Carlsson S, Roobol MJ, Steineck G and Wiklund P: Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: Observational study of mortality outcomes. BMJ. 348:g15022014. View Article : Google Scholar : PubMed/NCBI
8	Abdollah F, Sun M, Thuret R, Jeldres C, Tian Z, Briganti A, Shariat SF, Perrotte P, Rigatti P, Montorsi F and Karakiewicz P: A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988–2006. Eur Urol. 59:88–95. 2011. View Article : Google Scholar : PubMed/NCBI
9	Merino T, San Francisco IF, Rojas PA, Bettoli P, Zúñiga A and Besa P: Intensity-modulated radiotherapy versus radical prostatectomy in patients with localized prostate cancer: Long-term follow-up. BMC Cancer. 13:5302013. View Article : Google Scholar : PubMed/NCBI
10	Sun M, Sammon JD, Becker A, Roghmann F, Tian Z, Kim SP, Larouche A, Abdollah F, Hu JC, Karakiewicz PI and Trinh QD: Radical prostatectomy vs radiotherapy vs observation among older patients with clinically localized prostate cancer: A comparative effectiveness evaluation. BJU Int. 113:200–208. 2014. View Article : Google Scholar : PubMed/NCBI
11	Bluethmann SM, Mariotto AB and Rowland JH: Anticipating the ‘silver tsunami’: Prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol Biomarkers Prev. 25:1029–1036. 2016. View Article : Google Scholar : PubMed/NCBI
12	Muramatsu N and Akiyama H: Japan: Super-aging society preparing for the future. Gerontologist. 51:425–432. 2011. View Article : Google Scholar : PubMed/NCBI
13	Fukagai T, Namiki TS, Carlile RG, Yoshida H and Namiki M: Comparison of the clinical outcome after hormonal therapy for prostate cancer between Japanese and Caucasian men. BJU Int. 97:1190–1193. 2006. View Article : Google Scholar : PubMed/NCBI
14	Namiki M, Ueno S, Kitagawa Y, Fukagai T and Akaza H: Effectiveness and adverse effects of hormonal therapy for prostate cancer: Japanese experience and perspective. Asian J Androl. 14:451–457. 2012. View Article : Google Scholar : PubMed/NCBI
15	Mohler JL, Armstrong AJ, Bahnson RR, D'Amico AV, Davis BJ, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, et al: Prostate Cancer, Version 1.2016. J Natl Compr Canc Netw. 14:19–30. 2016. View Article : Google Scholar : PubMed/NCBI
16	Kanda Y: Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 48:452–458. 2013. View Article : Google Scholar : PubMed/NCBI
17	Robinson D, Garmo H, Lissbrant IF, Widmark A, Pettersson A, Gunnlaugsson A, Adolfsson J, Bratt O, Nilsson P and Stattin P: Prostate cancer death after radiotherapy or radical prostatectomy: A nationwide population-based observational study. Eur Urol. 73:502–511. 2018. View Article : Google Scholar : PubMed/NCBI
18	Viani GA, Viana BS, Martin JE, Rossi BT, Zuliani G and Stefano EJ: Intensity-modulated radiotherapy reduces toxicity with similar biochemical control compared with 3-dimensional conformal radiotherapy for prostate cancer: A randomized clinical trial. Cancer. 122:2004–2011. 2016. View Article : Google Scholar : PubMed/NCBI
19	Yu T, Zhang Q, Zheng T, Shi H, Liu Y, Feng S, Hao M, Ye L, Wu X and Yang C: The effectiveness of intensity modulated radiation therapy versus three-dimensional radiation therapy in prostate cancer: A meta-analysis of the literatures. PLoS One. 11:e01544992016. View Article : Google Scholar : PubMed/NCBI
20	Shimizuguchi T, Nihei K, Okano T, Machitori Y, Ito K and Karasawa K: A comparison of clinical outcomes between three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer. Int J Clin Oncol. 22:373–379. 2017. View Article : Google Scholar : PubMed/NCBI
21	Löser A, Beyer B, Carl CO, Löser B, Nagaraj Y, Frenzel T, Petersen C, Krüll A, Graefen M and Schwarz R: Toxicity and risk factors after combined high-dose-rate brachytherapy and external beam radiation therapy in men ≥75 years with localized prostate cancer. Strahlenther Onkol. 195:374–382. 2019. View Article : Google Scholar : PubMed/NCBI
22	Fang FM, Wang YM, Wang CJ, Huang HY and Chiang PH: Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone. Jpn J Clin Oncol. 38:474–479. 2008. View Article : Google Scholar : PubMed/NCBI
23	D'Amico AV, Manola J, Loffredo M, Renshaw AA, DellaCroce A and Kantoff PW: 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: A randomized controlled trial. JAMA. 292:821–827. 2004. View Article : Google Scholar : PubMed/NCBI
24	Hanks GE, Pajak TF, Porter A, Grignon D, Brereton H, Venkatesan V, Horwitz EM, Lawton C, Rosenthal SA, Sandler HM, et al: Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The radiation therapy oncology group protocol 92-02. J Clin Oncol. 21:3972–3978. 2003. View Article : Google Scholar : PubMed/NCBI